The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|March 2, 2010
- Pharmaceutical Technology-03-02-2009
- Volume 33
- Issue 3
Pharmaceutical Technology, March 2010 Issue (PDF)
In Search of a Sterile Fill
Advertisement
Articles in this issue
over 17 years ago
New Leadership and More Resources Aim to Modernize FDA Operationsover 17 years ago
Coming Down the Pike: Treating Epilepsyover 17 years ago
Inside USP: Heparin Monographs Further Revisedover 17 years ago
Changes to Vial Labels May Affect Patient Safetyover 17 years ago
A Call for Transparency in Research and Marketingover 17 years ago
Critical Challenges Require Core Valuesover 17 years ago
Detective WorkAdvertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement